2-DG sensitized pancreatic cancer cells and tumors to inhibition of MEK [46], the kinase immediately upstream of MAPK3 in the RAS-induced kinase activation cascade. This evidence concerns the gene MAP2K7 and familial pancreatic carcinoma.